Anika Therapeutics, Inc. (ANIK) › Total AssetsAnika Therapeutics, Inc. (ANIK) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $128.94M2011: $132.84M2012: $142.07M2013: $156.04M2014: $192.81M2015: $235.75M2016: $240.25M2017: $282.62M2018: $278.99M2019: $330.71M2020: $365.61M2021: $347.54M2022: $349.13M2023: $270.63M2024: $202.74M2025: $190.27M$190.27M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$190.27M-6.2%2024$202.74M-25.1%2023$270.63M-22.5%2022$349.13M+0.5%2021$347.54M-4.9%2020$365.61M+10.6%2019$330.71M+18.5%2018$278.99M-1.3%2017$282.62M+17.6%2016$240.25M+1.9%2015$235.75M+22.3%2014$192.81M+23.6%2013$156.04M+9.8%2012$142.07M+6.9%2011$132.84M+3.0%2010$128.94M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share